INTRODUCTION — Alzheimer disease (AD) is a neurodegenerative disorder of uncertain cause and pathogenesis that mainly impacts senior adults. The fundamental clinical manifestations of AD are selective retentiveness deterioration and dementia. AD is the most frequent cause of dementia. While treatments are accessible that can modulate the course of the disease and/or improve many symptoms, there is no remedy, and the disease inevitably progresses in all patients.

This topic recaps the clinical manifestations and diagnosis of AD. Other topics review the risk factors and treatment of AD and the clinical manifestations of other causes of dementia and cognitive impairment.

DEMOGRAPHIC FEATURES — Alzheimer disease (AD) is characteristically a disease of senior years [1]. It is exceptional for AD to occur before age 60. The incidence and preponderance of AD increment exponentially with age.

AD is slightly more common in women than men, with a comparative risk of 1.5. This does not seem to be explicated by the greater longevity in women.

There are genetic grades of AD, all autosomal dominant, that routinely present before age 65, and frequently in the fifth decade or before. These account for less than 5 percent of all types of AD. Patients with Down syndrome acquire AD at an earlier age, 10 to 20 years younger than the broad population with AD.

Other risk categories for AD are discoursed on an individual basis.

CLINICAL FEATURES

Retentiveness impairment — Memory impairment is an essential feature of AD and is oftentimes its earliest manifestation. Even when not the primary complaint, retention shortfalls can be elicited in most patients with AD at the time of introduction.

The design of memory impairment in AD is also peculiar. Declarative memory for facts and outcomes, which reckon on mesial temporal and neocortical structures are profoundly impacted in AD, while subcortical systems supporting procedural memory and motor learning are relatively spared until rather late in the disease. A subset of declarative memory, that of particular events and contexts (episodic memory) is more profoundly impaired in early AD, compared with retentiveness for facts such as vocabulary and constructs (semantic memory), which oftentimes becomes impaired somewhat later. Semantic memory is encoded in neocortical (nonmesial) temporal areas.

Within episodic memory, there is a differentiation between immediate recall (eg, mental rehearsal of a telephone number), memory for recent events (which comes into play once material that has departed from cognisance must be recalled), and memory of more removed events. Memory for recent events, assisted by the hippocampus, entorhinal cortex, and related structures in the mesial temporal lobe, is prominently impaired in early AD. In direct contrast, immediate memory (encoded in the sensory association and prefrontal cortices) is spared early on, as are memories that are integrated for long periods of time (years), which can be retrieved without hippocampal function.

The early retentiveness deficit in AD is most precisely discovered as anterograde long-term episodic amnesia. Because the absolute time interval over which long-term memory can fail can actually be brief (eg, inability to recall a few words after a couple minutes of distraction), patients and primary care providers typically refer to “short-term memory” problems. For this reason, we try to avoid the confusion afforded by the technical terms of long-term and short-term memory and use the term “recent memory impairment” to refer to the characteristic impairment.

Memory deficits develop insidiously and build up slowly over time, evolving to include deficits of semantic memory and immediate recall. Deteriorations of procedural memory appear only in late phases of AD.

Memory is ordinarily tested by asking patients to recall three objects immediately and then at a delay of 5 to 10 minutes. Queries about orientation and recent current events are likewise useful memory tests. Clinicians should not rely on a patient’s report of memory impairment, as many older individuals are unreliable reporters of their own retention impairment and can both over and under approximate their deficits.

Amnestic mild cognitive impairment — A state of circumscribed anterograde long-term retentiveness impairment, with preserved general cognitive, sociable functioning is identified as amnestic mild cognitive impairment (MCI). Amnestic MCI is more and more recognized as an early point of AD, with a transition rate to dementia at about 10 to 15 percent per year.

Other facets of cognitive decline — Deficits in other cognitive fields may appear with or after the evolution of memory impairment. Speech function and visuospatial skills incline to be impacted comparatively early, while deficits in executive function and behavioural symptoms frequently manifest afterward in the disease course. These deficits appear and advance insidiously.

Language — Verbal dysfluency and anomia are often early characteristics of AD and are sometimes the exhibiting characteristic. The first manifestations of language disfunction usually include word-finding troubles, ambage, and decreased lexicon in instinctive language and with anomia on confrontational naming tests. This advances to include agrammatism, paraphasic errors, broken speech content, and impaired comprehension. Patients can usually repeat phrases word for word until the disease is quite advanced.

Language disfunction and departure of semantic memory are interconnected in AD. Some investigators have discovered that loss of semantic eloquence is an early determination in AD. When asked to give word lists in one minute’s time, patients with AD perform significantly worse on a category fluency test (eg, lists of animals) than on a letter fluency test (eg, lists of words starting with F). Typical execution is age associated, with at least 15 items expected at age 65.

Visuospatial skills — Loss of visuospatial skills is an early characteristic of AD that is sometimes very prominent at presentation. Visuospatial impairments manifest as malposition of details and difficulty navigating in first unfamiliar then common terrain. Ocular agnosia (inability to recognize objects) and prosopagnosia (inability to recognize faces) are more advanced characteristics. Numerous clinicians have noted hemispatial visual neglect in their patients with AD.

Visuospatial skills may be screened by asking patients to re-create simple figures (eg, crossed pentagons) and to make a clock face. The latter, when compounded with a request to fill in the time at “ten after eleven,” is a deceptively trying test and measures semantic cognition as well as executive and spacial operation.

Insight — Reduced perceptivity into his or her deficits (anosognosia) is a characteristic feature of AD and has been connected to frontal lobe pathology. It is commonplace for patients to underestimate their deficits and offer alibis or explanations for them when they are pointed out. Questioning a collateral historian, ordinarily a family member, who has known the patient over time, is helpful, and oftentimes it is the family member, not the patient, who takes the complaint of cognitive impairment to medical attention.

Loss of perceptivity increases over time along with overall disease severity. Comparative loss of insight is affiliated with behavioral disturbances; those with comparatively preserved insight are more liable to be depressed, while those with more impaired insight are likely to be agitated, disinhibited, and present psychotic features.

Apraxia — Dyspraxia, or trouble executing learned motor tasks, commonly comes about later in the disease after deficits in memory and language are apparent. Before it is clinically apparent, dyspraxia can be elicited by asking the patient to execute ideomotor tasks, ie, pantomime the use of tools (eg, “show me how you would use a comb”). Clinical dyspraxia leads to progressive difficulty first with involved, multi-step motor actions, then with getting dressed, eating, and other self-care tasks and is a primary contributor to dependence in mid to late phases of AD.

Executive function — In early stages of AD, damage in executive function may be subtle rather than obvious; family members and coworkers may find them less motivated and engaged. In addition to poor insight, depressed ability for abstract reasoning may be elicited. As the disease builds, a more apparent modification of personality, bad judgment and planning, and an unfitness to finish tasks typically emerges.

Neuropsychiatric symptoms — Neuropsychiatric symptoms are commonplace in AD, particularly in the intermediate and late path of disease. These can start out with subtle personality changes including indifference, social detachment, and disinhibition. The former may be a materialization of overlying clinical depression, which can be difficult to diagnose in the setting of dementia.

More troublesome in patient management is the emergence of behavioral interferences, including excitement, aggressiveness, wandering, and psychosis (hallucinations, delusions, misidentification syndromes). A resultant medical illness, medication toxicity, and other causes of delirium should be considered whenever new behavioral disturbances develop. The behavioral disturbances affiliated with AD are talked about in detail separately.

Assessment and Care
A new technology has been created to enhance behavioral health care and allow providers to better serve patients. BCNI, an innovative software program, aims to provide the clinician a rapid in-office procedure that produces a quantitative view of their patient’s neurocognitive status that is valid, reliable, objective, and reimbursable. Just as you carefully monitor the vital signs (weight. blood pressure, cholesterol, etc.) of your loved ones, consider the value of having a baseline for neurocognitive functions for those same patients.
BCNI power the tests and the neurocognitive testing has been in use by clinicians and researchers around the world. All patients, age 50 and older, are recommended to have a baseline neurocognitive test performed.

This type of testing has been utilized at respected institutions such as John Hopkins, Duke, UNC, Chapel Hill, the VA and clinical research sites in over 30 countries.
The BCNI assessment process itself is simple. A patient’s test s completed in approximately 30 minutes and is covered by most insurance as well as Medicare. The patient responds to stimuli on the screen by tapping a few keys on the keyboard. The assessment then utilizes scientifically validated objective tests to evaluate the neurocognitive status of the patient and covers a range of mental processes such as motor performance, attention, memory, reaction time and executive function. Following the assessment, a report and interpretation of the patient’s test results will be forwarded.
Medical professionals and researchers know that good health has many dimensions, one of the most important and yet least measured is the health of a patient’s brain. Now with the advent of BCNI clinicians have an east-to-use clinical tool that ineasures neurocognitive functions, such as Memory, Reaction Time,Psychomotor Speed, Complex Attention, and Cognitive Flexibility. Proper neurocognitive function is a major factor in determining a person’s quality of life.

The brain and central nervous system (CNS) have “vital signs,” but they have never been easy to objectively measure. Until now…
BCNI is effective in detecting early signs of dementia, Alzheimer’s, and tracking recovery from neurological problems. This computerized testing platform has been used:
• When lengthier assessments are either impractical or inappropriate
• Measured repeatedly or in patients in whom the diagnosis is known (e.g. mild and severe head injury or early neurodegenerative disease — early dementia and Alzheimer’s)
• To provide a valuable secondary clinical endpoint that may be an indicator for compliance or quality of life (e.g. psychiatric symptoms , chemo fog, fibro fog, sleep disorders, medication effects)
• In lengthy clinical treatment programs where minimal disruptions for cognitive assessment may be beneficial (e.g. cardiac surgery)
When the monitoring and management of medications is necessary (e.g. Alzheimer’s, depression, behavioral problems).

The psychometric characteristics of the tests are very similar to the characteristics of the conventional neuropsychological tests upon which they are based.
To learn more about BCNI call Senior PsychCare at 713-850-0049

This chart recap analysed the outcomes of effort upon neuropsychological appraisal and trial performance patterns amongst genuine and exaggerating patients, with and without neurological determinations, as aids to diagnosing symptom magnification.

The sampling consisted of 561 successive patients involved in compensation claims. With an adaptable neuropsychological exam (NPT) battery, the claims were evaluated across two days. The sampling included 303 patients measured for traumatic brain trauma, fifty-five patients with neurological disorders, and 203 patients evaluated for additional circumstances (for example, clinical depression or degenerative pain). A medium of thirty-eight ability measurements per patient were employed to render a general NPT domain grade. Composite tallies were likewise calculated for symptom cogency exams, self-report measures of psychiatrical symptoms, and memory complaint inventory. Seven NPT cognitive subdomain scores were multiply retroverted onto the symptom cogency exam composite, reporting for forty-five% of its aggregate discrepancy. Patients were likewise allotted to Genuine or Exaggerator groupings established upon symptom validity exam execution. The NPT for Exaggerating patients averaged 1.43 standard divergences beneath that of authenticated patients, indicating that NPT marks for most Exaggerating patients are underestimations of their genuine ability.

Factor analysis outcomes differed between these groupings. As a consequence, clinicians may avoid incorrectly identifying actual patients as exaggerating by integrating their self-reports of psychiatric symptoms and memory complaints into the symptomatic operation.

OBJECTIVE: To investigate to what extent dementia diagnoses of record in skilled nursing facilities (SNFs) are substantiated by verifiable neuropsychological examination information.

DESIGN: retroactive analysis of current neuropsychological screening data SETTING: Nursing facilities in New York (n = 11)

PARTICIPANTS: Nursing home occupants (n = 73)

INTERVENTION: Neuropsychological screening

MEASUREMENTS: standardised neuropsychological testing tools that included the Cognistat neurobehavioral condition exam, the Dementia ranking Scale-2 (DRS-2), the Wechsler abridged Scale of Intelligence (WASI), and the battery of the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD battery).

OUTCOMES: A sum of forty-one males and 32 females were studied. Of those examined, ten residents weren’t suspected of having dementia, but necessitated testing to determine the nature of certain cognitive charges portrayed. Of the other residents, forty-four had a demonstrated diagnosis of dementia in their medical history, and nineteen were referred because of a suspicion of dementia, but without any conventional diagnosis in the register. Established on information from the screening surveys, of those with demonstrated diagnoses, just seventeen (38.6%) fulfilled standards for dementia, while with those with “suspected” dementia, just three of the nineteen referred (15.7%) met standards. Of those that didn’t satisfy criteria but had an established dementia diagnosis in the record, approximately one-half met criteria for “Mild Cognitive Impairment” (MCI), a potential “predementia” condition that involves retention interference, but no additional cognitive impairment. The other half fulfilled criteria for an Axis I diagnosis, which, in this sampling, included for the most part clinical depression, but likewise examples of anxiousness and disobedience. For those with “suspected” dementia, the overwhelming absolute majority (eighty-four.2%) didn’t fit standards for a dementia diagnosis, with seventy-five% of those residents satisfying criteria for an Axis I diagnosis and twenty-five% meeting criteria for MCI. Just three of the nineteen “suspected” instances (15.7%) in reality met criteria for dementia, according to DSM-IV criteria.

CONCLUSION: Dementia diagnosings could be erroneous for several nursing home occupants. Utilizing representational measurement of cognitive operation generated by neuropsychological screening may result in higher diagnostic accuracy and help allow for more exact and pertinent treatment preparation.

The dizzying range of scales available for assessing dementia and mental disease in the aged can be whittled away to produce a requisite characterization of a single patient. First and foremost, these scales may be employed to build a baseline to monitor progress or worsening and to fulfill federal certification prerequisites in nursing homes, speakers articulated at the yearly gathering of the American Association for Geriatric Psychiatry.

“You should select scales that are concise, simple to grade and possess demonstrated validity and dependability,” stated Dr. Allan Anderson, manager of geriatric psychopathology at Shore Behavioral Health Services, Cambridge, Maryland.

Scales may heighten clinical practice and appraise the effectivity of psychiatric treatments, Dr. Anderson said.

Deborah Weber helps administrate scales to patients at Shore Behavioral Health. Usually, she said, she expends an hour or more with patients and their health care providers. The examinations are not utilized to constitute a diagnosis, she stated.

The Mini-Mental Status examination is among the most often administered scales at Shore Behavioral Health, Ms. Weber said. While this is a standard examination assessing cognitive power, it possesses several restrictions. Patients have to be fluid in English language, or they might not do well, she stated, adding that they likewise have to be literate. If they can not spell “world” forward, then they will not be competent to spell it reversed, she observes. The MMSE generally only uses up ten minutes to administer, but, she said, “do not hurry the patient–some patients take longer.”

Ms. Weber likewise applies many executive function exams, which now and again necessitate family or health care provider input. Illustrations include the Tinker Toy exam, Tower of Hanoi, and Proteus Mazes. Failure does not automatically entail dementia, she stated, remarking that medical illness or additional mental disorders may interfere with executive function. Eloquence tests–such as requiring patients to categorize items–are likewise beneficial means to evaluate executive function, she stated.

The clinician-administered CLOX test, formulated by Dr. Donald Royall, has quickly acquired followers, Ms. Weber said. It’s an effective exam, but “it is crucial that you realize the subtleties of this grading,” she stated.

To quantify clinical depression, she employs the Geriatric Depression and the Cornell Scale for Depression in Dementia. Independence may be evaluated with the Physical Self-Maintenance Scale or the Functional Activities Questionnaire, which demands just 5-10 minutes to finish, ranking the patient’s abilities in ten fields.

A different exam she likes is the Dementia Rating Scale II, which is clinician dispensed and computer graded, appraising competence in attention, origination/conservation, expression, conceptuality, and retention. Nevertheless, this exam is not responsive enough to discover modest varieties of dementia in folks who are intelligent or well tutored, Ms. Weber stated.

The selection of scales should be established on each patient’s particular needs, she said. Still, each battery should assess memory, executive routine, and actions of day-to-day living, she said.

For rest home patients, there are many scales that will help build a baseline of conduct and help satisfy federal documentation prerequisites under the Omnibus Reconciliation Act, said Dr. Alan Siegal of the department of psychological medicine at Yale, New Haven, Conn.

The Behave-AD can be executed in as little as ten minutes once the test-giver is acquainted with the formatting, he stated. This examination should be given by licensed nurses’ aides, as nurses are by and large too inundated, Dr. Siegal stated.

The patient is asked enquiries addressing demeanors over the last two weeks in 7 areas: paranoiac and neurotic ideation, delusions, activity disruptions, belligerence, cyclic rhythm perturbations, emotional disturbances, and anxieties and phobias. There are twenty-five queries with replies ordered from zero to three. The faculty is then expected to ascribe a global ranking from zero (not at all worrisome to the health professional or life-threatening to the patient) to three (seriously distressful or grievous).

The scale institutes a baseline documenting the conducts that contributed to a medicine, or other intervention, he stated.

Another valuable scale is the Cohen Mansfield Agitation Inventory. It supplies “a terrific thesaurus for ‘agitation,’” Dr. Siegal said. It likewise permits the health care provider to give the doctor a descriptive characterization of what’s going on with the patient. It just takes approximately 10-15 minutes to finish. The short form ranks fourteen fields of disturbed conduct, including hitting, verbal hostility, grabbing, perpetual requests for attention, repetitious sentences, strange laughter, and hiding or stashing things. The relative frequency of these behaviors is tabulated on a 5-point scale, from never to a couple of times an hour. Documenting the initial frequency allows for the psychiatric hospital and the clinician to present what progression has came about after several weeks of intervention, he stated.

Another scale that ranks relative frequency and harshness of demeanors is the Neuropsychiatric Inventory for Nursing Homes. The NPI is a bit more challenging to discharge but becomes less problematic with experience, doctor. Siegal alleged.

It has adept coinciding dependability with both the Hamilton Depression Scale and the Behave-AD, he stated, quantifying behaviors in twelve areas. If the symptom has been existing within the preceding month, the rater responds yes and then grades the frequence and harshness on a 4-point scale and health care provider suffering on a 0-5 scale. These scales are oftentimes employed to set up baselines for medication-based intervention, but pharmaceuticals are not always essential, Dr. Siegal stated.

Occasionally, it is as unproblematic as paying the patient a little attention, asking them how they’re making out, and acquiescing to a few requests, no matter how neurotic they may appear. This plan of attack can avert escalation and the demand for a pharmacological intervention, he stated.

Interventions are used as an adjunct to pharmaceutical treatment and can be classified within behavior, emotion, cognition or stimulation oriented approaches. Research on efficacy is reduced.

Behavioral Interventions
Behavioral interventions attempt to identify and reduce the antecedents and consequences of problem behaviors. This approach has not shown success in the overall functioning of patients, but can help to reduce some specific problem behaviors, such as incontinence. There is still a lack of high quality data on the effectiveness of these techniques in other behavior problems such as wandering.
Emotion-Oriented Interventions
Emotion-oriented interventions include reminiscence therapy, validation therapy, supportive psychotherapy, sensory integration or snoezelen, and simulated presence therapy. Supportive psychotherapy has received little or no formal scientific study, but some clinicians find it useful in helping mildly impaired patients adjust to their illness. Reminiscence therapy involves the discussion of past experiences individually or in group, many times with the aid of photographs, household items, music and sound recordings, or other familiar items from the past. Although there are few quality studies on the effectiveness of RT it may be beneficial for cognition and mood.  Simulated presence therapy is based on attachment theories and is normally carried out playing a recording with voices of the closest relatives of the patient. There is preliminary evidence indicating that SPT may reduce anxiety and challenging behaviors. Finally, validation therapy is based on acceptance of the reality and personal truth of another’s experience, while sensory integration is based on exercises aimed to stimulate senses. There is little evidence to support the usefulness of these therapies.
Cognition-Oriented Treatments
The aim of cognition-oriented treatments, which include reality orientation and cognitive retraining, is the restoration of cognitive deficits. Reality orientation consists in the presentation of information about time, place or person in order to ease the understanding of the person about its surroundings and his place in them. On the other hand, cognitive retraining tries to improve impaired capacities by exercitation of mental abilities. Both have shown some efficacy improving cognitive capacities, although in some works these effects were transient and negative effects, such as frustrations, have also been reported. Most of the programs inside this approach are fully or partially computerized and others are fully paper-based such as the Cognitive Retention Therapy method.
Stimulation-Oriented Treatments
Stimulation-oriented treatments include art, music and pet therapies, exercise, and any other kind of recreational activities for patients. Stimulation has modest support for improving behavior, mood, and, to a lesser extent, function. Nevertheless, as important as these effects are, the main support for the use of stimulation therapies is the improvement in the patient daily life routine they suppose.
Summary of research:
Out of 1632 total studies reviewed, roughly 10% of them were included in the review. Objective was to determine the level of quality of the studies and the effectiveness of the results. Main theories of the studies explored were as follows: Reminiscence Therapy – using household materials, family pictures and old newspapers to stimulate memories and hopefully have the participant share their experiences. Results were dependent on reality orientation and were largely insignificant. Validation Therapy – Based on personal uniqueness, promotes validating feelings of unfinished conflicts. Results were inconclusive and insignificant. Reality Orientation Therapy – Uses reminders about information such as day, time and location. Results were insignificant. Cognitive Stimulation Therapy – Uses information processing. Results varied but were very positive in improving aspects of neuropsychiatric symptoms immediately and for many months after. Also improved mood, and delayed institutionalization. Other dementia-specific therapies – “individualized special instruction” and “self-maintenance therapy” Results may have been a product of environment but concluded an improvement to behavior and depression. Non-dementia-specific therapies – Included many different varieties of treatments. Most were inconclusive. Positive results were achieved using ‘life review, sensory stimulation’ and other personalized techniques. Music Therapy – Helps reduce agitation and irnprove ehavior during sessions and immediately after, however no long term benefits. Snoezelen therapy – Possible improvement in disruptive behavior during sessions, effects are only apparent for a short time after. Sensory stimulation includes calming effects during sessions and no long term usefulness. Simulated presence therapy – Includes possible reduction in agitation and no other real benefits. Therapeutic activity programs include results varied but overall were inconsistent and inconclusive with no real benefits. Social interaction includes possible improvement in neuropsychiatric symptoms in some participants. Decreased sensory stimulation includes no real benefits. Environmental Manipulation include changing the visual environment, adding or removing mirrors, signposting, unlocking doors and other environmental manipulations such as group living. Results showed a possible reduction in agitation and improvement with orientation, with no other real benefits. Other studies focused on psycho education of staff and family member’s ability to manage behavioral problems. Results showed individual education was more effective then groups in being useful to treat neuropsychiatric symptoms.
Conclusions:
Only behavior management therapies, specific types of caregiver and residential care staff education, and possibly cognitive stimulation appear to have lasting effectiveness for the management of dementia-associated neuropsychiatric symptoms. Lack of evidence regarding other therapies is not evidence of lack of efficacy. Conclusions are limited because of the paucity of high-quality research (only nine level-I studies were identified). More high-quality investigation is needed.

If you are like most folks, you probably believe that memory troubles are the first signaling of Alzheimer’s. Not true, according to 2 recent reports.

A University of Kansas study ascertained that years prior to memory loss takes place, there may be a decay in other cognitive skills. According to the report, which came out in the Archives of Neurology, having difficulty completing a jigsaw puzzle or interpreting a map may be a few of the first cautionary signs.

These spatial skills commenced to wane quickly a whole 2 years before any descent in memory skills was observed. In the report, a diagnosis of Alzheimer’s was arrived at approximately one year after the psychological deterioration was observed.

Another report from the University of Alabama discovered a declination in financial skills in the year before acquiring Alzheimer’s. This year-long work centered on participants who were already displaying signs of modest cognitive disability.

The volunteers who advanced to Alzheimer’s by the close of the survey felt a larger dip in their power to execute day-to-day financial actions, such as balancing a checkbook or splitting up a restaurant invoice, than those who did not acquire the disease.

Neither of these reports show that sustaining difficulty balancing your checkbook or interpreting a map implies that you’ll acquire Alzheimer’s. But these primal cautionary signs could help physicians arrive at an earlier diagnosis in folks who are at risk for the disease or who are demonstrating signs of moderate cognitive damage.

With Alzheimer’s, early diagnosis is vital. In the volume I coauthored with Dr. William Shankle, Preventing Alzheimer’s disease, we talk about how early diagnosing and handling could retard symptoms long enough to allow for you to live out your lifetime independently.

For anybody who’s at risk for Alzheimer’s or anybody who would like to* promote cognitive routine, I advocate consuming the Amen Clinics NeuroMemory supplementation. This unusual method has taken a long time to formulate and it functions by beneficially regulating acetylcholine, the neurotransmitter involved with knowledge and retentiveness.

If you’re worried about your risk for Alzheimer’s, consider the Shankle-Amen Early Dementia detecting Questionnaire. You will be able to get a transcript of it in Preventing Alzheimer’s. You may likewise have the Amen Clinics Memory Screen examination online. It is free. Simply click the succeeding hyperlink:

Memory Screen Test

WHY: Approximately 15 – 60 % of elderly patients experience a delirium prior to or during a hospitalization but the diagnosis is missed in up to 70% of cases. Delirium is associated with poor outcomes such as prolonged hospitalization, functional decline, and increased use of chemical and physical restraints. Delirium increases the risk of nursing home admission. Individuals at high risk for delirium should be assessed daily using a standardized tool to facilitate prompt identification and management. Risk factors for delirium include older age, prior cognitive impairment, presence of infection, severe illness or multiple co-morbidities, dehydration, psychotropic medication use, alcoholism, vision impairment and fractures.

BEST TOOL: The Confusion Assessment Method (CAM) includes two parts. Part one is an assessment instrument that screens for overall cognitive impairment. Part two includes only those four features that were found to have the greatest ability to distinguish delirium or reversible confusion from other types of cognitive impairment.

VALIDITY/RELIABILITY: Concurrent validation with psychiatric diagnosis revealed sensitivity of 94-100% and specificity of 90-95%. The CAM significantly correlated with the Mini-Mental Status Examination, the Visual Analog Scale for Confusion and the digit span test.

STRENGTHS AND LIMITATIONS: The tool can be administered in less than 5 minutes.

It closely correlates with DSM-IV criteria for delirium. There is a false positive rate of 10% and the instrument has not been widely tested as a bedside tool for nurse raters. The tool identifies the presence or absence of delirium but does not assess the severity of the condition, making it less useful to detect clinical improvement or deterioration.

FOLLOW-UP: The presence of delirium as indicated by the algorithm, warrants prompt intervention to identify and treat underlying causes and provide supportive care. Vigilant efforts need to continue across the healthcare continuum to preserve and restore baseline mental status.

Permission is hereby granted to reproduce this material for not-for-profit educational purposes only, provided The Hartford Institute for Geriatric Nursing, Division of Nursing, New York University is cited as the source. Available on the internet at www.hartfordign.org. E-mail notification of usage to: hartford.ign@nyu.edu.

By Christine M. Waszynski RN, C, MS, APRN

Because 50-90% of patients are undiagnosed with dementia and other brain or psychiatric problems that lead to behavior problems they are under treated or over treated. This often results in difficulties with Medicare surveyors with the consequences of F501, F329, F330 and F429 tags. Senior PsychCare, in cooperation with nursing staff, has developed a progress to conduct initial screening s on all patients. We utilize objective tests to evaluate the neurocognitive status of patients and cover a range of . mental processes, such as motor performance, attention, and memory if there is suspicion of a problem. We ten have professionals so neuro behavioral evaluations and if indicated a more comprehensive computer assessment called BCNI (Borrell Cognitive Neuropsychiatric Inventory) is conducted. This assessment allows to:

• Establish and document current status and use in later treatment decisions

• This distinguishes early mild or subtle behavioral problems in patients through comparison to other individuals his/her age

• This leads to decision making on the course of action to take. Counseling, medications, and social eatments to maintairr quality of life are provided:

• It helps families understand the problem that effect emotion and behavior. Also it allows making a prediction of the future functions, emotional, and social needs to improve the quality of life.

Senior PsychCare will make best efforts to use the evaluation to direct treatment in collaboration with the family, facility, staff and primary care physician. More information about the screening process is available by contacting Tammy Simon, FIR Director at SPC, at 713 850 0049. Based on the fact that we are committed to providing the best and available care, we are providing there services under the professional staff of your long-term health care center. Thus we comply and are compliant with all HIPAA regulations.

Thank you for your time.

Sincerely,

Leo J Borrell

Medical Director